196 related articles for article (PubMed ID: 22412893)
1. Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors.
Lützner N; De-Castro Arce J; Rösl F
PLoS One; 2012; 7(3):e32590. PubMed ID: 22412893
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
Clem AL; Hamid T; Kakar SS
Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
[TBL] [Abstract][Full Text] [Related]
3. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.
Armengol S; Arretxe E; Rodríguez L; Ochoa B; Chico Y; Martínez MJ
Biochimie; 2013 Apr; 95(4):735-42. PubMed ID: 23160072
[TBL] [Abstract][Full Text] [Related]
4. An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene.
Hewetson A; Chilton BS
J Biol Chem; 2003 Oct; 278(41):40177-85. PubMed ID: 12890680
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human EDF-1 minimal promoter: involvement of NFY and Sp1 in the regulation of basal transcription.
Bolognese F; Pitarque-Martì M; Lo Cicero V; Mantovani R; Maier JA
Gene; 2006 Jun; 374():87-95. PubMed ID: 16567061
[TBL] [Abstract][Full Text] [Related]
6. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.
Jun DY; Park HS; Lee JY; Baek JY; Park HK; Fukui K; Kim YH
Gene; 2008 May; 414(1-2):106-14. PubMed ID: 18378410
[TBL] [Abstract][Full Text] [Related]
7. FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop.
Lützner N; Kalbacher H; Krones-Herzig A; Rösl F
PLoS One; 2012; 7(7):e42166. PubMed ID: 22848740
[TBL] [Abstract][Full Text] [Related]
8. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
9. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
Ekizoglu S; Dalay N; Karaman E; Akdeniz D; Ozaydin A; Buyru N
Transl Res; 2013 Aug; 162(2):122-9. PubMed ID: 23810581
[TBL] [Abstract][Full Text] [Related]
10. NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.
Dong S; Kanno T; Yamaki A; Kojima T; Shiraiwa M; Kawada A; Méchin MC; Chavanas S; Serre G; Simon M; Takahara H
Biochem J; 2006 Aug; 397(3):449-59. PubMed ID: 16671893
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of cis- and trans-regulatory elements involved in expression of phospholipid hydroperoxide glutathione peroxidase.
Ufer C; Borchert A; Kuhn H
Nucleic Acids Res; 2003 Aug; 31(15):4293-303. PubMed ID: 12888488
[TBL] [Abstract][Full Text] [Related]
12. Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.
Zhao J; Bilsland A; Hoare SF; Keith WN
FEBS Lett; 2003 Feb; 536(1-3):111-9. PubMed ID: 12586348
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor Y is required for basal activation and chromatin accessibility of fibroblast growth factor receptor 2 promoter in osteoblast-like cells.
Sun F; Xie Q; Ma J; Yang S; Chen Q; Hong A
J Biol Chem; 2009 Jan; 284(5):3136-3147. PubMed ID: 19047043
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the human cystathionine beta-synthase -1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3.
Ge Y; Konrad MA; Matherly LH; Taub JW
Biochem J; 2001 Jul; 357(Pt 1):97-105. PubMed ID: 11415440
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.
Nicolás M; Noé V; Ciudad CJ
Biochem J; 2003 Apr; 371(Pt 2):265-75. PubMed ID: 12513689
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.
Jean D; Guillaume N; Frade R
Biochem J; 2002 Jan; 361(Pt 1):173-84. PubMed ID: 11742542
[TBL] [Abstract][Full Text] [Related]
19. The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells.
Ajore R; Kumar P; Dhanda RS; Gullberg U; Olsson I
BMC Mol Biol; 2012 Mar; 13():11. PubMed ID: 22443175
[TBL] [Abstract][Full Text] [Related]
20. NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2).
Mahishi L; Usdin K
Biochem J; 2006 Dec; 400(2):327-35. PubMed ID: 16886907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
